You are using an outdated browser. Please upgrade your browser to improve your experience.

copanlisib

Ligand Summary
Ligand Structure
Rendered image for the query structure
Description
Copanlisib is an inhibitor of phosphatidylinositol-3-kinase (PI3K) with inhibitory activity predominantly against PI3K-alpha and PI3K-delta isoforms expressed in malignant B cells. Copanlisib has been shown to induce tumor cell death by apoptosis and inhibition of proliferation of primary malignant B cell lines. Copanlisib inhibits several key cell-signaling pathways, including B-cell receptor (BCR) signaling, CXCR12 mediated chemotaxis of malignant B cells, and NFkB signaling in lymphoma cell lines.
Synonyms & Links
DrugCentral: 5256
LyCHI:  H3234GC54PVS


Target Activities